Malaria Vaccine Market

Market Overview:

The global malaria vaccine market is expected to exhibit a CAGR of around 34% during 2022-2030.

Malaria refers to a disease caused by the plasmodium parasite which is transmitted to the human body from the bite of infected mosquitoes. Malaria vaccine refers to a biological component that stimulates the production of antibodies to mitigate the risk of contracting malaria. Some common symptoms of malaria include fever, fatigue, nausea, headaches, chills, etc. Malaria vaccines can be administered in several ways, including intramuscular, subcutaneous, and intradermal injections. These vaccines can be widely categorized into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine.

Malaria Vaccine Market Trends:

The increasing prevalence of malaria, particularly across tropical countries, is primarily driving the global malaria vaccine market. Additionally, several government and non-government organizations are launching favorable initiatives to spread awareness regarding disease prevention as well as the importance of immunization among the masses, especially in the endemic and rural regions. This, in turn, is creating a positive outlook for the market. Furthermore, the introduction of pre-erythrocytic vaccines, commonly known as anti-infective vaccines, that target the plasmodium parasite and prevent progression to chronic blood-stage diseases is also augmenting the market growth. Apart from this, several pharmaceutical companies are focusing on the development of new and improved malaria vaccines by accelerating the clinical trials of various pipeline drugs. Moreover, continuous technological advancements, including the advent of novel adjuvants and cutting-edge vaccine delivery platforms, are expected to drive the global malaria vaccine market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria vaccine market report, along with forecasts at the global, and regional level from 2022-2030. Our report has categorized the market based on type, agent, route of administration and distribution channel.

Breakup by Type:

• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-Antigen Vaccine
• Others
   

Breakup by Agent:

• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species
   

Breakup by Route of Administration:

• Intramuscular
• Subcutaneous
• Intradermal
• Others
   

Breakup by Distribution Channel:

• NGO/Non-Profit Organization
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
   

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Key Questions Answered in This Report:

• How has the global malaria vaccine market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the agent?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global malaria vaccine market and who are the key players?
• What is the degree of competition in the industry?